Use the Back button in your browser to see the other results of your search or to select another record.
A repeated short educational intervention improves asthma control and quality of life |
Plaza V, Peiro M, Torrejon M, Fletcher M, Lopez-Vina A, Ignacio JM, Quintano JA, Bardagi S, Gich I, on behalf of the Prometheus Study Group |
The European Respiratory Journal 2015 Nov;46(5):1298-1307 |
clinical trial |
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
We assessed the effectiveness of an asthma educational programme based on a repeated short intervention (AEP-RSI) to improve asthma control (symptom control and future risk) and quality of life. A total of 230 adults with mild-to-moderate persistent uncontrolled asthma participated in a 1-year cluster randomised controlled multicentre study. The AEP-RSI was given in four face-to-face sessions at 3-month intervals, and included administration of a written personalised action plan and training on inhaler technique. Centres were randomised to the AEP-RSI (intervention) group or usual clinical practice group. Specialised centres using a standard educational programme were the gold standard group. A significant improvement in the Asthma Control Test score was observed in all three groups (p < 0.001), but improvements were higher in the intervention and gold standard groups than in the usual clinical practice group (p = 0.042), which also showed fewer exacerbations (mean +/- SD 1.20 +/- 2.02 and 0.56 +/- 1.5 versus 2.04 +/- 2.72, respectively) and greater increases in the Mini Asthma Quality of Life Questionnaire scores (0.95 +/- 1.04 and 0.89 +/- 0.84 versus 0.52 +/- 0.97, respectively). The AEP-RSI was effective in improving asthma symptom control, future risk and quality of life.
|